SCHEMBL4565198

SCHEMBL4565198

CC(=O)C1=CNCC(C)(C)c2c1[nH]c1ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 7/20 0.40
ESR1 P03372 1/20 0.38
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
NR3C2 P08235 1/20 0.38
AR P10275 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPKAPK2 P49137 1/20 0.36
KMT2A Q03164 2/20 0.36
IDO1 P14902 1/20 0.36
PTPN1 P18031 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
MAPT P10636 2/20 0.36
PARP14 Q460N5 1/20 0.36
LMNA P02545 1/20 0.36
BAZ2B Q9UIF8 1/20 0.36
OPRM1 P35372 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1966306 0.89 NR1H4 (0.40) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4710200 0.88 NR1H4 (0.39) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL29881447 0.83 NR1H4 (0.59) NR1H4KDM4EKMT2AMAPTLMNA
SCHEMBL275052 0.83 NR1H4 (0.59) NR1H4KDM4EKMT2AMAPTLMNA
SCHEMBL1243024 0.83 NR1H4 (0.59) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4520941 0.79 NR1H4 (0.48) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4534131 0.79 NR1H4 (0.48) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4758761 0.79 NR1H4 (0.44) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL18347369 0.79 KIF11 (0.38) NR1H4PGRKDM4EMAPKAPK2KMT2A
SCHEMBL4758763 0.78 NR1H4 (0.46) NR1H4ESR1NR3C1PGRNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203577-A1 Azepinoindole Derivatives As Pharmaceutical Agents EXELIXIS, INC. (US) 2009-08-13 US disclosed
US-20090203577-A1 Azepinoindole Derivatives As Pharmaceutical Agents EXELIXIS, INC. (US) 2009-08-13 US disclosed
US-20090203577-A1 Azepinoindole Derivatives As Pharmaceutical Agents EXELIXIS, INC. (US) 2009-08-13 US disclosed
WO-2007070796-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2007-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203577-A1 Azepinoindole Derivatives As Pharmaceutical Agents NR1H4, NR1I2, GPBAR1 NR1H4 1/4885ESR1 292/4885NR3C1 231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.